Semi-rational design improves the catalytic activity of butyrylcholinesterase against ghrelin.
- Author:
Yingting CAI
1
;
Tianzhu ZHANG
1
;
Fengyun LIN
1
Author Information
- Publication Type:Journal Article
- Keywords: butyrylcholinesterase; ghrelin; semi-rational design; soluble expression; thermostability
- MeSH: Ghrelin/genetics*; Butyrylcholinesterase/genetics*; Humans; Escherichia coli/metabolism*; Mutation; Catalysis; Recombinant Proteins/metabolism*
- From: Chinese Journal of Biotechnology 2024;40(11):4228-4241
- CountryChina
- Language:Chinese
- Abstract: Ghrelin, a hormone mainly produced and released by the stomach, has numerous functions, including releasing growth hormones, regulating appetite, and processing sugar and lipids. Researchers have made great efforts to study the relationship between ghrelin and metabolic diseases. It is believed that human butyrylcholinesterase (hBChE) could hydrolyze ghrelin to the inactive form (desacyl-ghrelin). However, the low catalytic activity of wild hBChE against ghrelin hinders the clinical application. Recently, a soluble catalytically active hBChE mutant was successfully expressed in Escherichia coli for the first time. We then adopted HotSpot Wizard 3.0 to analyze the mutant structure and rationally selected 10 mutants. Furthermore, we determined the catalytic activities of the mutants against several substrates and the thermostability of these mutants. The results showed that the mutants E197D and A199S improved catalytic activity against ghrelin by 4.6 times and 3.5 times, respectively. The findings provide clues for treating endocrine diseases with the agents for regulating ghrelin.
